Selected publications:
Markaki I, Ntetsika T, Sorjonen K, Svenningsson P; BioPark Study Group. Euglycemia Indicates Favorable Motor Outcome in Parkinson’s Disease. Mov Disord. 2021 Feb 26. doi: 10.1002/mds.28545.
Full publications:
- Impaired migratory phenotype of CD4+ T cells in Parkinson's disease
- Correction To: TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP- 363856
- Impaired Aversive Memory Formation in GPR37L1KO Mice
- Single-cell transcriptomics reveals correct developmental dynamics and high-quality midbrain cell types by improved hESC differentiation
- Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson's disease and Lewy body dementia
- Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington's disease: a study of linked Swedish National Registries (2002-2019)
- Decreased Prosaposin and Progranulin in the Cingulate Cortex Are Associated with Schizophrenia Pathophysiology
- Prosaposin Reduces α-Synuclein in Cells and Saposin C Dislodges it from Glucosylceramide-enriched Lipid Membranes
- High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations
- TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP-383856
- PRC2-mediated repression is essential to maintain identity and function of differentiated dopaminergic and serotonergic neurons
- Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)
- Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy
- Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels
- Glucocerebrosidase variant T369M is not a risk factor for Parkinson's disease in Sweden